...
首页> 外文期刊>Frontiers in Pharmacology >The Role of Biomaterials as Angiogenic Modulators of Spinal Cord Injury: Mimetics of the Spinal Cord, Cell and Angiogenic Factor Delivery Agents
【24h】

The Role of Biomaterials as Angiogenic Modulators of Spinal Cord Injury: Mimetics of the Spinal Cord, Cell and Angiogenic Factor Delivery Agents

机译:生物材料作为脊髓损伤的血管生成调节剂的作用:脊髓,细胞和血管生成因子传递剂的模拟物。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Spinal cord injury (SCI) represents an extremely debilitating condition for which no efficacious treatment is available. One of the main contributors to the inhospitable environment found in SCI is the vascular disruption that happens at the moment of injury that compromises the blood-spinal cord barrier (BSCB) and triggers a cascade of events that includes infiltration of inflammatory cells, ischemia and intraparenchymal hemorrhage. Due to the unsatisfactory nature of revascularization following SCI, restoring vascular perfusion and the BSCB seems an interesting way of modulating the lesion environment into a regenerative phenotype, with a potential increase in functional recovery. Certain biomaterials possess interesting features to enhance SCI therapies, and in fact have been applied as angiogenic promoters in other pathologies. The present mini-review intends to highlight the contribution that biomaterials could make in the development of novel therapeutic solutions able to restore proper vascularization and the BSCB.
机译:脊髓损伤(SCI)代表一种极为虚弱的病症,对于该病症没有有效的治疗方法。 SCI中发现的恶劣环境的主要原因之一是在受伤时发生的血管破裂,损害了血脊髓屏障(BSCB)并触发了一系列事件,包括炎症细胞浸润,局部缺血和实质内出血。由于SCI后血运重建的不令人满意的性质,恢复血管灌注和BSCB似乎是将病灶环境调节为再生表型的有趣方法,功能恢复可能会增加。某些生物材料具有增强SCI治疗的有趣特征,并且实际上已在其他病理学中用作血管生成促进剂。本小型审查旨在强调生物材料在开发能够恢复适当血管生成和BSCB的新型治疗解决方案方面的贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号